2017 has clearly brought many changes in our world, both internal and external to CARRA. Time will tell what the impact of political and economic forces will be on our organization, but there is one certainty: CARRA must prepare to be able to withstand the many challenges that we are likely to face in the next few years to continue and build on the progress and momentum that we have all worked to create in the last few years.
CARRA has enjoyed astounding growth and change in the last few years (http://www.the-rheumatologist.org/article/future-pediatric-rheumatology-grounded-evolution-childhood-arthritis-rheumatology-research-alliance/). Now more than ever, we must focus and align our collective energy with CARRA’s mission, core values and operating principles. This means we have to work together to build unity and consensus around our research strategies, more clearly define and standardize processes and procedures, and maintain the transparency and democratic principles upon which CARRA was founded.read more
Applications due April 7, 2017 CARRA is pleased to announce a new Research Informatics Training Internship intended to advance informatics-related research in Pediatric Rheumatology by increasing the pool of independent informatics researchers in our field. Through...read more
Applications due April 28, 2017 CARRA is funding up to 3 travel grants for Early Investigator to attend the Pediatric Rheumatology European Society (PReS) annual meeting and PReS Young Investigator Meeting in Athens, Greece from September 13 through September 17....read more
CARRA offers its members several funding opportunities that leverage the CARRA network to further research, positively impact the pediatric rheumatology scientific community, and advance the CARRA mission. For more information on these opportunities, please visit the Grants & Funding page.
STOP-JIA STUDY OVERVIEW
The Childhood Arthritis and Rheumatology Research Alliance (CARRA), Inc. announced today that the first two patients had enrolled in the Start Time Optimization in Polyarticular Juvenile Idiopathic Arthritis (STOP-JIA) project. STOP-JIA aims to answer a critical question facing patients and doctors: “When is the best time to start biologic medications in polyarticular JIA?”read more
We are very excited to announce that CARRA had a record year for membership growth! We had 125 new members join in 2016, bringing our current membership total to...read more
You can now initiate a request for data through the Data Request Portal for the following datasets: CARRA Legacy Registry CARRA 2 Registry Other CARRA-related databases (CTP pilots, APPLE) Access the web-based submission portal for data requests via the CARRA...read more
A couple weeks ago, our administrator received an email that sent our division into panic. The title of the email was “URGENT,” in all caps, followed by three exclamation points. It was a warning of a possible draft of a new executive order that would limit entry into...read more